A Clinical Trial to Study the Safety and Efficacy of Chandrakanthi Choornam in Patients With Low Sperm Count
Ключови думи
Резюме
Описание
METHODOLOGY OF PROPOSED RESEARCH:
I. Preclinical study II. Clinical study
I. PRECLINICAL STUDY:
Standardization Of The Study Drug
1. Botanical Identification
2. Chemical Identification
3. Preparation of the study drugs:
Formulation: Chandrakanthi choornam Source : Chikicharathna deepam Part II. Pg-168 (Approved sastric book as per drugs & cosmetic act 1940.
4. Chemical methods of testing
5. Pharmacological study : A. Spermotogenic Activity
6. Toxicological study : A. Acute Toxicity B. Long term Toxicity
II. CLINICAL STUDY
Conducted as per the guidelines of GCP accepted by Ayush adapted from the ICH.
A. Pilot study B. Main study
Дати
Последна проверка: | 07/31/2014 |
Първо изпратено: | 08/26/2014 |
Очаквано записване подадено: | 09/03/2014 |
Първо публикувано: | 09/08/2014 |
Изпратена последна актуализация: | 09/03/2014 |
Последна актуализация публикувана: | 09/08/2014 |
Действителна начална дата на проучването: | 11/30/2012 |
Приблизителна дата на първично завършване: | 03/31/2014 |
Очаквана дата на завършване на проучването: | 07/31/2014 |
Състояние или заболяване
Интервенция / лечение
Drug: Chandrakanthi choornam
Фаза
Групи за ръце
Arm | Интервенция / лечение |
---|---|
Experimental: Chandrakanthi choornam Chandrakanthi Choornam (CKC) - 12gm in milk
OD dose; Oral route
3 Months - duration
Intervention Drug: Chandrakanthi Choornam (CKC) | Drug: Chandrakanthi choornam 12gm in milk - OD dose; Oral route; 3 Months ( 90days) - duration
Preparation from approved sastric book as per drugs & cosmetic act 1940 |
Критерии за допустимост
Възрасти, отговарящи на условията за проучване | 21 Years Да се 21 Years |
Полове, допустими за проучване | Male |
Приема здрави доброволци | Да |
Критерии | Inclusion criteria: - Male infertile Patients with age between 21-45 yrs - Marriage history for >1 year - Abnormal Sperm count 1-15 million/ml - Patients with normal Liver & Renal function test - Willing to give specimen of semen before & at the end of the clinical trial - Informed patients giving written consent Exclusion criteria: - Azoospermia - complete absence of sperm cells in the ejaculate - Aspermia - complete lack of semen - Necrospermia- Spermatozoa in semen are either immobile or dead. - Clinical diagnosis of Varicocele & Hydrocele - History of Undescended testis - Inguinal hernia on physical examination - Male accessory gland infection - History of DM, Hypertension and Cardiac disease - Any recent medical or surgical illness - Underwent treatment for promoting Spermatogenic fertility in last 3 months - Other Systemic disease requiring specific therapies - Known Thyroid disease - Past history of Renal, Hepatic or any other chronic illness in the Patient |
Резултат
Първични изходни мерки
1. Sperm concentration per milliliter of seminal fluid [90 days]
2. Proportion of Sperm motility [90 days]
3. Proportion of Sperm morphology [90 days]
Вторични изходни мерки
1. Impact on the hormonal level due to the clinical trial [90 days]
Други изходни мерки
1. Assessment on Safety parameters [90 days]